XML 70 R52.htm IDEA: XBRL DOCUMENT v3.8.0.1
Acquisition of Senhance Surgical Robotic System - Additional Information (Detail)
12 Months Ended
Dec. 30, 2016
EUR (€)
shares
Sep. 21, 2015
USD ($)
shares
Dec. 31, 2017
EUR (€)
Dec. 31, 2015
USD ($)
Dec. 31, 2016
USD ($)
Dec. 30, 2016
USD ($)
Dec. 30, 2016
EUR (€)
Sep. 21, 2015
EUR (€)
Business Acquisition [Line Items]                
Securities consideration held in escrow percentage   10.00%            
Escrow and security interest period   24 months            
Escrow and security interest expiration date   Sep. 21, 2017            
Legal, consulting and other costs related to acquisition       $ 4,231,000        
Minimum [Member]                
Business Acquisition [Line Items]                
Amortization period     5 years          
Maximum [Member]                
Business Acquisition [Line Items]                
Amortization period     10 years          
Senhance Surgical Robotic System Acquisition [Member]                
Business Acquisition [Line Items]                
Common shares issued | shares   15,543,413            
Cash consideration   $ 25,000,000            
Intellectual property, net   $ 48,500,000            
Amortization period   7 years            
Senhance Surgical Robotic System Acquisition [Member] | First Tranche [Member]                
Business Acquisition [Line Items]                
Cash consideration   $ 25,000,000            
Senhance Surgical Robotic System Acquisition [Member] | Second Tranche [Member]                
Business Acquisition [Line Items]                
Common shares issued | shares 3,722,685              
Cash consideration payable | €             € 10,000,000  
Aggregate fair market value | € € 5,000,000              
Aggregate fair market value payment | €             € 5,000,000  
Gross proceeds from financing           $ 50,000,000    
Interest rate           9.00% 9.00%  
Senhance Surgical Robotic System Acquisition [Member] | Second Tranche [Member] | Lincoln Park Capital Fund, LLC [Member]                
Business Acquisition [Line Items]                
Gross proceeds from financing         $ 50,000,000      
Interest rate         9.00%      
Senhance Surgical Robotic System Acquisition [Member] | Second Tranche [Member] | Minimum [Member]                
Business Acquisition [Line Items]                
Cash on hand           $ 50,000,000    
Senhance Surgical Robotic System Acquisition [Member] | Second Tranche [Member] | Minimum [Member] | Lincoln Park Capital Fund, LLC [Member]                
Business Acquisition [Line Items]                
Cash on hand         $ 50,000,000      
Senhance Surgical Robotic System Acquisition [Member] | Third Tranche [Member]                
Business Acquisition [Line Items]                
Cash consideration payable | €               € 15,000,000
Senhance Surgical Robotic System Acquisition [Member] | Third Tranche [Member] | Minimum [Member]                
Business Acquisition [Line Items]                
Target revenue to be achieved | €               25,000,000
Senhance Surgical Robotic System Acquisition [Member] | Fourth Tranche [Member]                
Business Acquisition [Line Items]                
Cash consideration | €     € 1,800,000          
Cash consideration payable | €               2,500,000
Senhance Surgical Robotic System Acquisition [Member] | U.S. Dollars [Member]                
Business Acquisition [Line Items]                
Cash consideration   $ 25,000,000            
Senhance Surgical Robotic System Acquisition [Member] | Euro [Member]                
Business Acquisition [Line Items]                
Cash consideration payable | €               € 27,500,000
TransEnterix Italia [Member]                
Business Acquisition [Line Items]                
Membership interests percentage under Security agreement   10.00%           10.00%
Legal, consulting and other costs related to acquisition       $ 4,200,000